Rekombinante Adeno-Assoziierte Virale Vektoren zur Multilateralen Genverabreichung

Details

Veröffentlichungs-Nr.

EP4768593

Anmeldetag

14. Juli 2021

Veröffentlichung

1. Juli 2026

Rechtsraum

EP

IPC

C12N15/85

Abstract

Provided herein are recombinant AAV vectors, AAV viral vectors, and capsid proteins for improved gene therapy, and methods for their manufacture and use in a multipartite (e.g., bipartite) delivery system. The vectors provide portions of transgene and direct their recombination in a cell to provide complete transgenes.

Anmelder

Firma

Abeona Therapeutics Inc.

Land

🇺🇸 USA

Fachgebiete